quarter of patients with radiographic CM-II become symptomatic, this subgroup is at the highest risk for developing devastating and potentially fatal neurological compromise secondary to brainstem and lower cranial nerve dysfunction or compression. 9, [15] [16] [17] We sought to assess the factors associated with poor outcomes in patients with symptomatic CM-II presenting to Children's Hospital of Pittsburgh.
Methods
A retrospective chart and radiology review was performed on all infants who had undergone primary closure of a myelomeningocele defect at Children's Hospital of Pittsburgh between 1995 and 2015. IRB approval was obtained. All myelomeningocele defects were treated with standard neurosurgical closure within 24 hours of birth. A total of 153 patients were identified; of these, 32 patients (21%) were found to have symptomatic CM-II during the study period. A total of 29 patients underwent CM-II decompression. Three patients were provided palliative care per family wishes and did not undergo CM-II decompression. Data collection points included Apgar scores, birth weight, anatomical level of defect (determined by radiograph), functional level of defect (lowest level of purposeful movement on either side of the body at 24 months of age or last neurological examination before death), presence of shunt-treated hydrocephalus, and ambulatory ability. Patients were seen regularly in a multidisciplinary spina bifida clinic every 3-6 months after the neonatal surgical repair and at least annually in long-term followup. Preoperative symptoms and signs leading to CM-II decompression (stridor, vocal cord paralysis, central apnea, etc.), as well as operative findings and postoperative changes in these symptoms and signs, were recorded in detail. Poor outcome was defined as death, stridor, or ventilator dependence. Deceased patients were separately assessed as a subgroup of poor outcome.
All 32 patients within our reported cohort received shunts early in life and prior to consideration of CM-II decompression. It is standard to always interrogate a shunt thoroughly prior to proceeding with decompression, as CM-II symptoms could be secondary to shunt malfunction. Patients presenting with new or recurrent symptoms undergo CT or MRI to assess for ventricular enlargement or transependymal flow, as well as a shunt series. If the findings are not conclusive for shunt failure, patients undergo a shunt tap or nuclear medicine study to assess for spontaneous flow and measure intracranial pressure. In cases of inconclusive results, patients undergo empirical shunt exploration prior to CM-II decompression. Patients who had no evidence of tethered cord were considered for repeat CM decompression if their syringes did not decrease in size postoperatively. Fourth ventricular-subarachnoid or subarachnoid-peritoneal shunts were placed for persistent syringomyelia in a second decompressive surgery after an initial CM-II decompression did not succeed in reducing the size of the syrinx.
Definitions
The size of the myelomeningocele defect was defined as the largest diameter of the skin defect in centimeters measured at the time of closure. The diagnosis of hydrocephalus was made by identifying a rapidly increasing head circumference crossing percentiles on the growth chart for gestational age and progressive ventriculomegaly on serial ultrasound examinations in alignment with the Hydrocephalus Clinical Research Network (HCRN) definition. 10 These findings were often accompanied by splaying of sutures, bulging of the anterior fontanel, or pseudomeningocele formation at the site of myelomeningocele repair; however, such clinical stigmata alone were insufficient to diagnose hydrocephalus in the absence of ventriculomegaly and macrocephaly. Symptomatic CM-II was defined as neurological findings attributable to herniation of the cerebellar vermis or brainstem compression in the absence of clear alternative etiologies (i.e., shunt failure, tracheal anomalies, etc.). Such clinical features include swallowing dysfunction, stridor, central apnea, opisthotonus, aspiration, weak cry or dysarthria, upper-extremity weakness, and spinal cord syrinx. Syrinx alone was insufficient justification for CM-II decompression.
Statistical Analysis
Student t-tests were used to compare the groups for dependent variables consisting of interval data for appropriate parametric continuous variables. Mann-Whitney tests were performed when appropriate for nonparametric variables. Pearson chi-square tests were used to compare groups for dependent variables consisting of categorical data. Statistically significant differences were determined by p values < 0.05. All statistical analyses were performed using standard statistical software (SAS version 9.4, SAS Institute, Inc.).
Results
Of the 32 patients meeting the inclusion criteria, 12 (37%) were found to have a poor outcome. Eight patients (25%) died since initial presentation, including 5 (16% of the overall cohort) who died within the 1st year of life and 3 (9%) who died during childhood or adolescence. Four of 13 patients who underwent decompression in the first 3 months of life died, whereas only 1 (6.3%) of 16 patients who underwent decompression after the first 3 months of life died (p = 0.14). Seven (44%) of 16 patients who developed symptoms in the first 3 months died, compared with 1 (6.3%) of 16 patients who developed symptoms later in life (p = 0.04). Only 1 death occurred in the 7 patients (14%) requiring decompression after 1 year of age, compared with 7 mortalities in the 25 patients (28%) who warranted decompression earlier in life (p = 0.64). Among the patients with myelomeningocele without symptomatic CM-II, 1 patient (0.8%) had died.
Presenting characteristics for the cohort are shown in Table 1 . Significant differences were not noted when comparing the good and poor outcome cohorts, but several differences in presenting characteristics were noted when comparing living and deceased patients. The median Apgar scores were 4.5 and 8 at 1 and 5 minutes of life, respectively, for patients who died and 8 and 9 for patients who survived (p = 0.006 and p = 0.1). The me-dian diameter of the myelomeningocele defect was 5.75 cm for patients who died and 5 cm for those who survived (mean of 5.7 cm and 4.5 cm, respectively) (p = 0.01). The anatomical level of defect trended toward higher levels in patients who died, with 4 (50%) of that group having an anatomical level at L-2 or higher, compared with 5 (25%) of the surviving patients (p = 0.06). The median head circumference at birth was 36.75 cm for patients who died, versus 34 cm for surviving patients (p = 0.1). Of note, the median head circumference for the 5 patients who died in the 1st year of life was 41.5 cm, versus 34 cm for all other patients (p = 0.01). A detailed review of the cases in which patients died is depicted in Tables 2 and 3 . The median follow-up for the entire cohort was 102 months. There was a notably shorter length of follow-up for patients in the poor outcome group (22.5 vs 132 months, p = 0.01), largely because of the early deaths. When excluding these patients from the calculation, the remaining patients in the poor outcome group had a mean follow-up of 72 months (p = 0.29).
Anatomical Characteristics of CM-II
Of the 32 patients in this cohort, 3 (9.4%) had brainstem and cerebellar vermian descent to the level of C-1, 13 (40.6%) had descent to the level of C-2, 6 (18.8%) had descent to the level of C-3, and 10 (31.3%) had descent to the level of C-4. There was no difference in the degree of vermian descent between the good and poor outcome groups (p = 0.86). Twenty-one patients (65.6%) had associated syringomyelia. In 13 cases (61.9%) there was a holocord syrinx, in 2 cases (9.5%) there was a cervical syrinx, in 3 cases (14.3%) there was a cervicothoracic syrinx, and in 3 cases (14.3%) there was a thoracolumbar syrinx (Table 4 ). There was no statistically significant difference in syrinx presence (p = 0.15) or syrinx type between the 2 subgroups (p = 0.51).
Associated Operations
All 32 of the patients who underwent CM-II decompression also underwent ventriculoperitoneal shunt placement (median age at shunt placement: 4 days). Overall, 135 (88%) of 153 patients with spina bifida underwent 
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CSF shunting within our cohort. The median age at shunt placement for patients in the poor outcome group was 1 day of life, compared with 4 days in the good outcome group (p = 0.1). The median age at placement for patients who died was 1 day compared with 4 days in those who survived (p = 0.025). Twenty-nine (90.6%) of the symptomatic patients underwent CM-II decompression via multilevel laminectomy. Both patients who did not undergo CM-II decompression were candidates for surgery; given their poor prognoses and additional comorbidities, the families elected to pursue a redirection of care toward comfort measures prior to their deaths. Nineteen patients (65.6%) underwent a single CM-II decompression, 5 (17.2%) underwent 2 decompressions, and 5 (17.2%) underwent 3 decompressions. There was no significant difference in multiple decompression frequency between the poor and good outcome groups (p = 0.14). Eleven patients (34.4%) underwent tethered cord releases; 2 of these patients were in the poor outcome group and 9 were in the good outcome group (p = 0.41). Eight patients (25%) required tracheostomy; 4 were in the poor outcome group and 4 were in the good outcome group (p = 0.2). The median age at tracheostomy was 0.54 years in the poor out- come group and 0.27 years in the good outcome group (p = 0.78). It should be noted, however, that 3 patients in the poor outcome group were respirator dependent but did not survive long enough to require tracheostomy, which potentially confounds this comparison. Eleven patients (34.4%) required gastrostomy tube placement; 5 of these patients were in the poor outcome group and 6 were in the good outcome group (p = 0.7). The median age at gastrostomy was 0.21 years for the poor outcome group and 0.27 years for the good outcome group (p = 0.79). Two patients (6.3%), both with good outcomes, underwent correction of scoliosis (p = 0.93), and 2 patients (6.3%), 1 in each cohort, required correction of postlaminectomy kyphosis (p = 0.71) ( Table 5) .
Operative Characteristics and Outcomes
Twenty-two (75.9%) of 29 patients who underwent CM-II decompression did so within the 1st year of life, and an additional 3 were judged to have warranted decompression but died prior to intervention. During CM-II decompression, laminectomies were performed in all cases. Two patients (6.9%) had a C-1 laminectomy alone, 8 patients (27.6%) had C-1 and C-2 laminectomies, 7 patients (24.1%) had laminectomies down to C-3, and 12 patients (41.4%) had laminectomies down to C-4. The number of laminectomies did not correlate with outcome (p = 0.83). In 26 (89.7%) of the patients who underwent decompression surgery, expansile duraplasty was performed. One patient had abundant redundant dura, which was used for closure; Values are number of patients unless otherwise indicated.
this patient unfortunately underwent a second emergent decompression in the context of cerebellar infarction after severe shunt failure and brainstem herniation 4 years later. Two patients did not have dural opening per surgeon preference, one in the good outcome group and one in the poor outcome group. Neither underwent repeat decompression. Postoperatively, syrinx improvement was documented in 4 cases (19%), syrinx stability was documented in 9 cases (42.9%), syrinx worsening was documented in 3 cases (14.3%), and syrinx outcome was not documented in 5 cases (23.8%) due to loss to follow-up not related to mortality (Table 6 ). There was no significant difference in rates of expansile duraplasty or syrinx improvement between the 2 groups (p = 0.22 and p = 0.42).
In this study, we noted substantial variations in symptom resolution with decompression. Only 9 (43%) of 21 patients with family-reported swallowing dysfunction were reported to have improvement in this condition on long-term postoperative follow-up. In contrast to reported improvement, 7 (58%) of the 12 patients documented to have aspiration on preoperative barium swallow studies had resolution of their aspiration postoperatively, whereas 2 patients without documented preoperative swallowing dysfunction developed aspiration on long-term follow-up. Vocal cord dysfunction was moderately responsive to decompression, with 5 (56%) of 9 patients with vocal cord paralysis on initial laryngoscopy having resolution postoperatively, and 8 (75%) of 12 patients with documented stridor having resolution postoperatively. All patients underwent postoperative laryngoscopy. The median time for initial postoperative laryngoscopy was 4 months. The median time until vocal cord function improvement was 13 months. The median time until the detection of improvement in stridor was 2.5 months. Half of patients (50%) with documented central apnea had complete resolution postoperatively, with a median time of improvement of 3 months. No differences in presenting symptoms were noted between the poor outcome group and good outcome group, but 7 (88%) of the 8 patients who died were found to have central apnea upon presentation compared with 5 (21%) of the 24 living patients (p = 0.001) ( Tables 7 and 8 ).
Summary of Cases in Which Patients Underwent Repeat Decompression

Case 1
This 7-year-old girl underwent an initial CM-II decompression for increasing upper-extremity paresis and enlargement of a cervicomedullary syrinx. She developed obtundation, hypertension, and vocal cord paralysis 4 days postoperatively. After imaging and a shunt tap consistent with a functioning device, she underwent repeat CM-II with widening of the decompression, shunt revision, and transoral odontoidectomy over the ensuing days as her symptoms progressed to locked-in syndrome, following which her family chose to redirect care and she died.
Case 2
This 11-month-old girl had undergone CM-II decompression at 8 months of age prior to presenting with progression of her cervicothoracic syrinx and new-onset vocal cord paralysis, which persisted despite shunt revision. She underwent repeat decompression, which partially improved her vocal cord paralysis and stabilized her syrinx.
Case 3
This 7-year-old boy, who had undergone decompression 5 years previously, presented with his typical shunt failure symptoms of headaches and neck pain and was found to have a nonfunctional shunt. After shunt revision, his condition initially improved, but then he developed repeat symptoms of shunt failure later that same day with rapid cognitive decline requiring intubation, after which he was found to have fixed and dilated pupils. Interrogation of the shunt did not demonstrate CSF flow, and so an external ventricular drain (EVD) was placed. The patient's examination findings improved and pupillary dilation re- Values are number of patients (%).
solved, but he was found to have developed brainstem infarction and swelling. Repeat CM-II decompression was performed, but unfortunately the patient remained in a persistent vegetative state.
Case 4
This 2-year-old boy had undergone decompression surgery at age 1 month. He developed progression of his thoracolumbar syrinx and worsened lower back and leg pain. After repeat decompression, the syrinx stabilized and the patient's symptoms improved.
Case 5
This 2-year-old boy, who underwent decompression in infancy, was found to have worsening myelopathy and progression of his holocord syrinx on follow-up. He underwent repeat decompression, which stabilized his syrinx and symptoms.
Case 6
This 3-year-old girl, who underwent CM-II decompression at age 2, subsequently developed a progressive cervicothoracic arachnoid cyst and a cervical syrinx. She underwent a cyst resection at that time but presented again with worsening stridor and a holocord syrinx. Thus, she underwent another decompression procedure at age 4, resulting in improvement of her syrinx and symptoms.
Case 7
This 4-year-old boy, who had undergone CM-II decompression 3 years prior, developed a bulbar syrinx and swallowing difficulties. He underwent repeat decompression. His symptoms improved and his syrinx stabilized postoperatively.
Case 8
This 3-year-old girl initially underwent CM-II decompression at 1 year of age after holocord syrinx enlargement. The syrinx continued to expand over the subsequent year despite the initial decompression, and so a repeat decompression was performed at age 2 years, but unfortunately the syrinx continued to expand after that procedure. Approximately a year subsequently a third decompression with thoracic subarachnoid-peritoneal shunt placement was performed with improvement of the syrinx.
Case 9
This 15-year-old girl had initially undergone CM-II decompression at age 1 year but presented with worsening syringobulbia and swallowing dysfunction at age 2 years. She underwent repeat decompression with good results. Unfortunately, at age 15 she represented with worsening swallowing function and syrinx progression, and so she underwent a third decompression procedure and placement of a fourth ventricular-subarachnoid shunt with good postoperative results and syrinx reduction.
Case 10
This 2.5-year-old patient had undergone CM-II decompression at age 5 months due to apneic spells and at age 6 months had undergone resection of a presacral mass with intradural involvement. Since the resection, the patient had begun having repeated episodes of apnea, and an MRI study demonstrated an enlarged cervical syrinx with downward herniation but no clear CSF leak from the presacral resection. A repeat decompression with fourth ventricular-subarachnoid shunt was performed at age 7 months and the patient improved in terms of syrinx size and apnea. Two years later, the patient developed sleep apnea and was found to have an enlarged syrinx once again. He underwent repeat decompression with revision of the subarachnoid-peritoneal shunt, to good effect.
Discussion
In this report, we demonstrate in our 20-year cohort of patients with CM-II and myelomeningocele that 1) symptomatic CM-II patients had a 15% mortality rate during infancy and a 25% long-term mortality rate; 2) patients with poor Apgar scores at birth, central apnea, larger myelomeningocele defects, and greater initial head circumference had a higher mortality rate; and 3) patients that developed symptoms within the first 3 months of life had the highest mortality rate. Of the 8 deaths in this case series, 5 occurred within the patients' 1st year of life, and all of these were associated with severe central apnea since birth as well as a number of comorbid conditions, including cranial nerve dysfunction, sepsis (unrelated to wound or shunt complications), and other organ dysfunction ( Table 2 ). Three of the 5 patients who died within their 1st year of life did not undergo CM-II decompression due to the families' wishes, although they were eligible. Importantly, the median head circumference of these 5 infants was significantly higher than that of the remainder of the cohort. The patients who died in infancy underwent shunt placement at an earlier age, consistent with their dramatic macrocephaly and ventriculomegaly. The underlying mechanism promoting rapid neurological decline in infancy is unclear but may correlate to a greater level of congenital dysplasia within the developing brain, which has been suggested to underlie severe and refractory symptoms in CM-II patients and may predispose patients to poor functional outcome even after CSF diversion and adequate posterior fossa decompression. 2, 5 Specifically, the cerebral aqueduct may be compressed, stenotic, or dysplastic, predisposing to hydrocephalus as part of a greater brainstem dysgenesis. 2, 3 Other factors associated with mortality included poor initial Apgar scores at 1 minute and larger myelomeningocele defect diameter. A higher level of anatomical defect was also noted, which is associated with worse motor function (a higher motor level) in spina bifida. 6, 8 In our study, a substantial number of patients did not have documentation of syrinx improvement and in several cases had syrinx worsening. This may in part be secondary to our general practice of not routinely obtaining postoperative imaging studies of the spinal canal in patients with no attributable symptoms and in whom MRI is logistically or medically challenging. Among those who did undergo postoperative MRI, the mean amount of time between surgery and the most recent MRI screening was 89 months, with all but 3 patients having more than 2 years of imaging follow-up. The rate of syrinx resolution in CM-II relative to that in type I Chiari malformation is unclear, in part due to the fact that many published series report outcomes without documentation of actual syrinx improvement. 19 A total of 10 patients underwent surgical reexploration. Three patients underwent repeat decompression within 3 months for progressive clinical symptoms and syrinx enlargement. Six patients underwent repeat decompression 1-13 years after the initial surgery for new brainstem symptoms, myelopathy, and syrinx enlargement. Two patients underwent 2 repeat decompressions several years apart for the same symptoms. Two patients underwent fourth ventricular-subarachnoid shunting at the time of repeat decompression, and 1 patient underwent subarachnoid-peritoneal shunting at the time of repeat decompression (Table 8) .
Pollack et al. reported on a cohort that was similar in size to our cohort and also comprised patients treated at our institution, but from 1975 to 1989. 17 In that cohort, the diagnoses were heavily based on the clinical development of brainstem signs after CSF diversion, with 52% of the patients becoming symptomatic within the first 3 months of life. This was similar to our more recent cohort (50% of patients in our new cohort became symptomatic within the first 3 months of life). Three (12%) of 25 patients died during the follow-up period in the older series, in contrast to 8 (25%) of 32 in our current series. Interestingly, the ages of the 3 patients at the time of death within the older cohort were 12 months, 12 months, and 35 months. This distribution of deaths differs significantly from that in our current cohort, in which mortality was heavily weighted toward patients presenting with symptoms in the first 3 months of life and ultimately dying within the 1st year of life in 5 of 8 cases. Three patients within our current cohort died during late childhood (age 6, 8, and 12 years). In the first case, progressive syringobulbia and syringomyelia occurred, leading to respiratory failure despite repeated surgical decompression and shunting. In the second case, the patient declined after a hypoxic brain injury secondary to a protracted seizure episode, which led to ventilator dependency. In the third case, the patient contracted influenza and succumbed to anoxic brain injury from respiratory failure. This patient had previously been ventilator dependent at night and was unable to compensate with the added burden of disease. The median followup was 38 months in Pollack and colleagues' older cohort, and the duration of follow-up might not have been long enough to detect such late deaths related to the long-term consequences of CM-II. The remaining 5 patient deaths in our current cohort occurred earlier (at 7 days, 9 days, 11 days, 64 days, and 9 months of age). We included 3 patients who died prior to CM-II decompression at 7, 9, and 11 days of age.
Compared with the series reported by Pollack et al., in the present series vocal cord paresis was less associated with mortality (p = 0.32), although central apnea was more highly associated. It may be that sicker infants are surviving in the current era due to advances in maternal-fetal medicine and neonatal care, and thus more neonates with dysplastic brainstems are able to survive to reach neurosurgical care. This may be associated with earlier neurosurgical response to symptoms of critical brainstem compression due to the ease of acquiring confirmatory imaging, as well as the knowledge of the clinical and anatomical consequences of delayed decompression. 4, 14, 17, 20 Early studies on the efficacy of multilaminar decompression in neonates were controversial due to high rates of perioperative mortality despite intervention, greater than 60% in many cases. 15, 21 Our mortality rate among patients qualifying for CM-II decompression in the first 3 months of life was 41%, and among those qualifying for decompression in the 1st year of life the mortality rate was 28%, including the 3 patients who did not undergo decompression due to poor prognosis and familial wishes. Excluding those 3 cases, the mortality rate among neonates under-going decompression within 3 months of birth was 31%, and for those undergoing decompression within 1 year of birth the mortality rate was 18.2%. While operative experience in neonatal CM-II decompression has increased with time, we suggest that several other factors have contributed substantially to mortality reduction at our center, including aggressive critical care in the neonatal period, the greater prevalence of early diagnostic testing for signs of brainstem compression, the performance of early surgical decompression when symptoms are detected, and close monitoring in our multidisciplinary spina bifida clinic. Respiratory dysfunction and failure were heavily represented among the cases in which patients died, with these presenting with central apnea as an early sign of brainstem compression at a rate that was significantly higher than among those who survived. However, many surviving patients were noted to have respiratory dysfunction as well. Early intervention for respiratory issues is critical to improving quality and duration of life. 12 Through the spina bifida clinic, a close relationship with otolaryngology may have also allowed for the identification and treatment of respiratory issues before they could reach a critical level. Patients with spina bifida are seen on a monthly basis for the first 6 months of life, and then every 3 months until age 2. Visits are gradually reduced to annually on an individualized basis. Patients are typically seen 3 months postoperatively in the spina bifida clinic after CM-II decompression, and laryngoscopic evaluation is scheduled if needed. Many families feel that tracheostomy and gastrostomy are indicative of an inevitably poor prognosis. However, our data suggest that many patients fell within less severe outcome categories despite needing permanent or temporary gastrostomies and tracheostomies. The fact that improvement in vocal cord dysfunction may be substantially delayed compared with other symptomatic improvement should be emphasized to parents with concerns regarding tracheostomy and quality of life.
Limitations
This is a retrospective study, and thus the data are limited in granularity. In addition, the relative infrequency of this malformation in children prevents single-center investigations from being well powered. It is likely that some differences between poor and good outcome groups were not detected due to these 2 factors.
Conclusions
CM-II in myelomeningocele is associated with a significant mortality rate even when early surgical intervention is performed. In this series, death was more frequent in symptomatic patients presenting within the first 3 months of life and was associated with central apnea, larger head circumference, higher spinal level of myelomeningocele defect, larger myelomeningocele defect, and lower Apgar scores. Late deaths were associated with symptom progression or exacerbation despite aggressive surgical and medical intervention. Half of the patients experienced resolution in swallowing dysfunction, aspiration, stridor, and/or vocal cord dysfunction with maximal surgical intervention.
